GotoPER - Physicians' Education Resource
Back to Home
Free CE/CMEVideo

Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?

Create AccountAlready Registered? Login Here

Release Date

July 11, 2025

Expiration Date

July 12, 2026

Credits

1.5 CME, NCPD

Specialties

Lung Cancer, Medical Oncology+1 more

Release Date: July 11, 2025

Expiration Date: July 11, 2026

Activity Overview

This educational activity is an archive of the live presentation held on Saturday, May 31, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, NP/PAs, and other HCPs involved in the treatment and management of SCLC.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the biology of DLL3 and its role as a target in SCLC due to its restricted expression profile and absence in normal adult tissues.
  • Analyze the development and mechanisms of action of T-cell-engaging antibodies and CAR T-cell therapies targeting DLL3 in SCLC.
  • Evaluate the latest trial data on DLL3-targeting therapies in SCLC.
  • Implement strategies to monitor and mitigate common adverse effects of DLL3-targeted therapies and evidence-based management strategies.
Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Amgen, Inc, and Boehringer Ingelheim Pharmaceuticals, Inc.

Related Content

Course

Medical Crossfire®: DLL3-Driven Innovations in Small Cell Lung Cancer – How Do Experts Apply Pivotal Advances to Practice?

Create Account